His first case: the mysterious closure of Yadu’s Pav Bhaji, followed by an epic farm adventure with Swapna Di. In the ...

Merck & Co. lowered the top end of its full-year sales forecast after demand for its HPV vaccine fell for a second straight quarter in China. Sales of the Gardasil shot, which is given to ...

The Gardasil franchise is the company's second largest sales driver behind Keytruda, and Merck remains steadfast it can garner more than $11 billion from the key product in 2030. Fewer than 10% of ...

Davis, chairman and chief executive officer, Merck. "Our pipeline is advancing and expanding, demonstrating our success in creating a sustainable innovation engine, and positioning Merck with a ...

Are you a print subscriber? Activate your account. 37 min 58 sec ago By Tim Nudd - 1 hour 18 min ago By Brandon Doerrer - 2 hours 10 min ago By Ad Age Staff - 2 hours 51 min ago By Asa Hiken - 2 ...

Hello! Today we take note of the antagonism between gene-editing players Prime Medicine and Tessera Therapeutics, consider the issue of whether the label should be updated on a Merck drug ...

The pace of mergers and acquisitions remained strong this week, with Kraft Heinz, Engineering software firm Altair, and Spirit Airlines grabbing headlines. Here's a list of other key deals this week: ...

Merck & Co., Inc.'s Q3 earnings report is anticipated on 31st October — next Thursday. Despite strong Q2 performance, Merck's stock fell due to a guidance downgrade related to issues with key ...

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair processes. Modifi Biosciences, a spin out of Yale University founded in 2021, ...

Oct. 23, 2024 (GLOBE NEWSWIRE) -- Modifi Biosciences, Inc. (“Modifi Biosciences”), a leader in the development of direct DNA modification enabled cancer therapeutics, today announced that the company ...